Cargando…
Efficacy of Recombinant Human Parathyroid Hormone versus Vertebral Augmentation Procedure on Patients with Acute Osteoporotic Vertebral Compression Fracture
OBJECTIVE: Although widely used in clinical practice, vertebral augmentation procedure (VAP) for osteoporotic vertebral compression fracture (OVCF) is not supported. Recently, the effect of recombinant human parathyroid hormone (1–34) (rhPTH) has been paid great attention for its efficacy in anti‐os...
Autores principales: | Gou, Pengguo, Zhao, Zhihui, Yu, Chen, Hou, Xuefeng, Gao, Gang, Zhang, Ting, Chang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531108/ https://www.ncbi.nlm.nih.gov/pubmed/36017765 http://dx.doi.org/10.1111/os.13470 |
Ejemplares similares
-
Advances in Vertebral Augmentation Systems for Osteoporotic Vertebral Compression Fractures
por: Long, Yufeng, et al.
Publicado: (2020) -
The Application of Vertebral Augmentation Procedures and Teriparatide in the Treatment of Osteoporotic Vertebral Compression Fractures [Response to Letter]
por: Kong, Meng, et al.
Publicado: (2020) -
Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures
por: Pan, Mingming, et al.
Publicado: (2019) -
Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures
por: Li, Qiujiang, et al.
Publicado: (2021) -
Transpedicle body augmenter for vertebral augmentation in symptomatic multiple osteoporotic compression fractures
por: Li, Allen, et al.
Publicado: (2010)